Obesity Trial, Recruiting NCT07431593 Sponsor: University of Rijeka Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07431593
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People with a body weight in the overweight range (BMI between 25.0 and 29.9) or in the obesity range (BMI of 30 or above)
  • People who are able to attend scheduled visits at the trial site
  • People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People who are currently pregnant or breastfeeding
  • People who are taking medications that suppress the immune system
  • People who have an active infection at the time of joining
  • People who have an inflammatory disease
  • People who have or have had cancer (malignancy)
  • People who have an acute illness that may affect immune system measurements
  • People who have any condition that the trial investigator determines would interfere with taking part in the study (confirm with trial site)
  • People who have a known blood disorder that affects white blood cell or platelet counts
  • People who have a long-term inflammatory condition that requires ongoing treatment affecting the whole body
  • People who have had major surgery within the last 3 months
  • People who have an immune disorder or similar condition that could affect the relationship between the study's immune measurements and obesity-related inflammation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gordana Kenđel Jovanović, Asst. Prof., Faculty of Medicine, University of Rijeka

Phone: +385912030704

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Rijeka
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
28 April 2027

Where this trial is recruiting

🇭🇷 Croatia

Primary endpoints

Diagnostic and prognostic value of SII and SIRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov